TransMedics (TMDX) Accumulated Expenses (2018 - 2026)

TransMedics' Accumulated Expenses history runs 9 years deep, the most recent figure standing at $19.9 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses fell 50.53% year-over-year to $19.9 million in Q1 2026; TTM through Mar 2026 was $19.9 million, a 50.53% decrease from a year earlier, with the FY2025 full-year figure at $28.4 million, down 37.01% from the prior year.
• Accumulated Expenses declined to $19.9 million in Q1 2026 per TMDX's latest filing, from $28.4 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $45.2 million in Q4 2024 and bottomed at $5.3 million in Q2 2022.
• The 5-year median for Accumulated Expenses is $28.4 million (2025), against an average of $27.5 million.
• Across the five-year window, Accumulated Expenses tumbled 55.98% in 2022 and jumped 329.17% in 2023, its largest moves.
• Year by year, Accumulated Expenses stood at $9.8 million in 2022, then soared by 289.53% to $38.2 million in 2023, then advanced by 18.13% to $45.2 million in 2024, then sank by 37.01% to $28.4 million in 2025, then tumbled by 30.19% to $19.9 million in 2026.
• Per Business Quant, the three latest TMDX Accumulated Expenses figures stand at $19.9 million (Q1 2026), $28.4 million (Q4 2025), and $24.3 million (Q3 2025).